###begin article-title 0
###xml 39 42 39 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ENG</italic>
###xml 44 50 44 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACVRL1</italic>
###xml 56 61 56 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMAD4</italic>
###xml 78 86 <span type="species:ncbi:9606">Patients</span>
Clinical Features and Mutations in the ENG, ACVRL1, and SMAD4 genes in Korean Patients with Hereditary Hemorrhagic Telangiectasia
###end article-title 0
###begin p 1
###xml 360 363 360 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ENG</italic>
###xml 404 410 404 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACVRL1</italic>
###xml 632 637 632 637 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMAD4</italic>
###xml 898 901 898 901 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ENG</italic>
###xml 906 912 906 912 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACVRL1</italic>
###xml 948 951 948 951 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ENG</italic>
###xml 1002 1005 1002 1005 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ENG</italic>
###xml 1021 1027 1021 1027 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACVRL1</italic>
###xml 1135 1140 1135 1140 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMAD4</italic>
###xml 1181 1184 1181 1184 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ENG</italic>
###xml 1189 1195 1189 1195 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACVRL1</italic>
###xml 544 552 <span type="species:ncbi:9606">patients</span>
###xml 656 664 <span type="species:ncbi:9606">patients</span>
###xml 755 763 <span type="species:ncbi:9606">patients</span>
###xml 969 976 <span type="species:ncbi:9606">patient</span>
###xml 1044 1052 <span type="species:ncbi:9606">patients</span>
###xml 1086 1094 <span type="species:ncbi:9606">patients</span>
###xml 1302 1310 <span type="species:ncbi:9606">patients</span>
###xml 1350 1358 <span type="species:ncbi:9606">patients</span>
Hereditary hemorrhagic telangiectasia (HHT) is an inherited disorder that is characterized by abnormal communication between the arteries and veins in the skin, mucosa, and various organs. HHT has been reported to show significant phenotypic variability and genetic heterogeneity with wide ethnic and geographic variations. Although mutations in the endoglin (ENG) and activin A receptor type II-like 1 (ACVRL1) genes have been known to cause HHT for more than 10 yr, little is known about the clinical features or genetic background of Korean patients with HHT. In addition, mutations in mothers against decapentaplegic homolog 4 (SMAD4) are also seen in patients with the combined syndrome of juvenile polyposis and HHT. This study examined five Korean patients with the typical manifestations of HHT such as frequent epistaxis and pulmonary arteriovenous malformations. Direct sequencing of the ENG and ACVRL1 genes revealed one known mutation, ENG c.277C>T, in one patient and two novel mutations, ENG c.992-1G>C and ACVRL1 c.81dupT in two patients, respectively. The remaining two patients with negative results were screened for SMAD4 mutations as well as gross deletions of ENG and ACVRL1 using multiple ligation-dependent probe amplification, but none was detected. Despite the small number of patients investigated, we firstly report Korean patients with genetically confirmed HHT, and show the genetic and allelic heterogeneity underlying HHT.
###end p 1
###begin title 2
INTRODUCTION
###end title 2
###begin p 3
###xml 279 280 279 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 391 392 391 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 393 394 393 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 674 676 674 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
Hereditary hemorrhagic telangiectasia (HHT), which is also known as Rendu-Osler-Weber disease, is an autosomal dominantly inherited disorder that is characterized by abnormal communications between the arteries and veins (telangiectasia) in the skin, mucosa, and various organs (1). The prevalence of this disorder is estimated to be -1:1,300 to -1:40,000 with some geographical variations (2-9). The clinical features of HHT include spontaneous recurrent epistaxis, mucocutaneous telangiectases (particularly on the tongue, lips, oral cavity, fingers and nose), and arteriovenous malformations (AVM) in the pulmonary, cerebral, hepatic, gastrointestinal or spinal vessels (10).
###end p 3
###begin p 4
###xml 116 119 116 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ENG</italic>
###xml 169 175 169 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACVRL1</italic>
###xml 197 199 197 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 201 203 201 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 471 472 471 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 474 476 474 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 477 479 477 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 611 614 611 614 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ENG</italic>
###xml 797 803 797 803 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACVRL1</italic>
###xml 1022 1023 1022 1023 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 1025 1027 1025 1027 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 1029 1031 1029 1031 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 1119 1121 1119 1121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 1123 1125 1123 1125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 1366 1371 1366 1371 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMAD4</italic>
###xml 1396 1398 1396 1398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 436 444 <span type="species:ncbi:9606">patients</span>
###xml 634 642 <span type="species:ncbi:9606">patients</span>
HHT is genetically heterogeneous and can be subdivided into HHT-1 and HHT-2 according to mutations in the endoglin (ENG) gene and the activin A receptor type II-like 1 (ACVRL1) gene, respectively (11, 12). These two subtypes are clinically indistinguishable and share many phenotypes. However, there appears to be some differences in the frequency of some their clinical manifestations. Pulmonary AVMs are believed to be more common in patients with HHT-1 than in HHT-2 (7, 13-17). Families with HHT-2 generally tend to show a later onset of the symptoms and a milder phenotype. The vast majority (-80%) of the ENG mutations in HHT-1 patients lead to premature stop codons and truncated peptides, with no apparent hot focus. On the other hand, more than half (-53%) of the mutations identified in ACVRL1 are missense substitutions, and the majorities of those mutations are located in exons 8, 7, and 3. Some large deletions and insertions as well as some splice site mutations in these two genes have also been reported (2, 13, 18). Recently, other loci for HHT, HHT-3, and HHT-4, were identified by linkage analysis (19, 20). Moreover, there are diseases presenting overlapping features with HHT such as the Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome (JPHT) which is caused by the mutations in the mothers against decapentaplegic homolog 4 (SMAD4) tumor suppressor gene (21).
###end p 4
###begin p 5
###xml 99 107 <span type="species:ncbi:9606">patients</span>
###xml 223 231 <span type="species:ncbi:9606">patients</span>
HHT is considered to be more common than previously believed. However, there are no data on Korean patients with genetically confirmed HHT. Therefore, this study examined the clinical and genetic information of five Korean patients with the typical manifestations of HHT.
###end p 5
###begin title 6
MATERIALS AND METHODS
###end title 6
###begin title 7
Subjects
###end title 7
###begin p 8
###xml 158 160 158 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 256 258 256 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 75 83 <span type="species:ncbi:9606">patients</span>
A clinical investigation and genetic analysis was performed in five Korean patients diagnosed with HHT according to the criteria suggested by Shovlin et al. (10). The frequency of epistaxis was graded according to the category suggested by Bergler et al. (22): grade 1, less than once per week; grade 2, a few times per week; grade 3, more than once per day.
###end p 8
###begin title 9
DNA sequence analysis
###end title 9
###begin p 10
###xml 250 253 250 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ENG</italic>
###xml 255 261 255 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACVRL1</italic>
###xml 267 272 267 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMAD4</italic>
After obtaining informed consent, the genomic DNA was isolated from the peripheral blood leukocytes using a Wizard Genomic DNA Purification kit according to the manufacturer's instructions (Promega, Madison, WI, U.S.A.). DNA sequence analysis of the ENG, ACVRL1, and SMAD4 genes was carried out using a polymerase chain reaction (PCR) with the primers designed by the authors. PCR was initially performed using a thermal cycler (model 9600, Applied Biosystems, Foster City, CA, U.S.A.), and DNA sequencing was carried out using an ABI Prism 3100 Genetic Analyzer with a BigDye Terminator Cycle Sequencing Ready Reaction kit (Applied Biosystems).
###end p 10
###begin title 11
Multiple ligation-dependent probe amplification (MLPA)
###end title 11
###begin p 12
###xml 225 228 225 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ENG</italic>
###xml 274 279 274 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACVRL</italic>
###xml 753 761 <span type="species:ncbi:9606">patients</span>
To identify the deletional mutations, MLPA was performed following the directions provided by MRCHolland, Amsterdam, The Netherlands (), using a probe set for HHT (SALSA MLPA KIT P093 HHT/PPH1) covering 13 of the 14 exons of ENG (except for exon 12) and all the 10 exons of ACVRL. MLPA was performed on the ABI 9700 thermocycler (Applied Biosystems). Amplicons were separated on a capillary sequencer (ABI 3130 genetic analyzer, Applied Biosystems). Before separation, Genescan-ROX 500 (Applied Biosystems) was added to the samples to facilitate estimation of fragment sizes. Data analysis was performed using the GeneScan (Applied Biosystems) and GeneMarker (SoftGenetics, State College, PA, U.S.A.) software. Relative peak area values obtained in the patients were compared to those obtained in healthy controls and were expressed as ratios. Signal ratios of approximately 0.5 were considered pathological.
###end p 12
###begin title 13
RESULTS
###end title 13
###begin title 14
Clinical findings
###end title 14
###begin p 15
###xml 98 105 98 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 267 277 267 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1A, B</xref>
###xml 361 368 361 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2A</xref>
###xml 581 591 581 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3A, B</xref>
###xml 66 74 <span type="species:ncbi:9606">patients</span>
###xml 107 114 <span type="species:ncbi:9606">Patient</span>
The Clinical features and mutations identified in the five Korean patients were summarized in the Table 1. Patient 1 had recurrent epistaxis and pulmonary AVM along with focal telangiectasia on the fingers (particularly the periungal regions), lips, and oral mucosa (Fig. 1A, B). A history of recurrent epistaxis was found in her father and 32-yr-old daughter (Fig. 2A). Computed tomography (CT) angiography of the liver showed an enlarged celiac axis and a prominent hepatic artery with multiple aberrant collateral vessels. Heterogeneous attenuation of the liver was also noted (Fig. 3A, B).
###end p 15
###begin p 16
###xml 358 365 358 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1C</xref>
###xml 477 484 477 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4A</xref>
###xml 0 7 <span type="species:ncbi:9606">Patient</span>
###xml 412 419 <span type="species:ncbi:9606">patient</span>
Patient 2 had pulmonary AVM and telelangiectasia was found on his tongue, along with a history of frequent epistaxis. Recurrent epistaxis histories were also found in his father, four sisters, and eight-year-old son. His father was diagnosed with HHT with recurrent massive epistaxis requiring frequent blood transfusions, telangiectasia on the oral mucosa (Fig. 1C), and pulmonary AVM. Pulmonary angiography of patient 2 revealed a large pulmonary AVM with an aneurysmal sac (Fig. 4A). Selective coil embolization of the feeder vessels of the pulmonary AVM was performed and the hemoptysis subsided.
###end p 16
###begin p 17
###xml 650 660 650 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3C, D</xref>
###xml 765 772 765 772 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4B</xref>
###xml 0 7 <span type="species:ncbi:9606">Patient</span>
Patient 3 experienced a momentary seizure-like movement and a sudden attack of aphasia. A history of frequent epistaxis and chronic anemia was found. At the age of 17, she had a pulmonary segmentectomy because of a pulmonary AVM. She had a family history of recurrent epistaxis (the detailed pedigree could not be obtained). Multiphase contrast-enhanced CT of the brain revealed an occlusion of the left intracranial artery at the middle cerebral artery (MCA) bifurcation level with findings of an acute infarct. Abdominal CT revealed a severe tortuous dilatation of the hepatic artery and its intrahepatic branches with mottled hepatic enhancement (Fig. 3C, D). Chest CT and pulmonary angiography revealed a new small-sized pulmonary AVM in the right middle lobe (Fig. 4B). A wedge resection was performed as a result. The transesophageal echocardiogram revealed a patent foramen ovale.
###end p 17
###begin p 18
###xml 718 725 718 725 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4C</xref>
###xml 0 7 <span type="species:ncbi:9606">Patient</span>
###xml 482 489 <span type="species:ncbi:9606">patient</span>
Patient 4, a 52-yr-old Korean female, was found to have a mass in the right parietal lobe of the brain. She complained of severe headache with fever, chill, nausea and vomiting. She had neck stiffness and microtelangiectasia on the trunk. She had a history of recurrent epistaxis and chronic anemia. There was a family history of epistaxis in her uncle and daughter (detailed pedigree could not be obtained), and her daughter had died suddenly from a hemangioma one year before the patient visited to our hospital. A brain pre- and post-contrast CT showed a rim-enhancing mass in the right parieto-temporal lobe suggesting an abscess with cavity formation. Pulmonary angiography revealed multifocal AVM in both lungs (Fig. 4C). Selective coil embolization of the AVM in the lung was performed, followed by a craniotomy and abscess drainage with the removal of the abscess wall.
###end p 18
###begin p 19
###xml 408 418 408 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1E, F</xref>
###xml 509 516 509 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4D</xref>
###xml 0 7 <span type="species:ncbi:9606">Patient</span>
Patient 5, a 21-yr-old Korean female, had severe dyspnea and a pulmonary AVM. She had a history of cyanosis, dyspnea, and clubbing of her fingers at birth, as well as multiple AVM in the lung. She underwent a segmentectomy of both lungs at the age of nine. A visual inspection revealed an acneiform eruption on her face, microtelangiectasia on the tongue, and clubbing fingers with one small telangiectasia (Fig. 1E, F). The chest CT and pulmonary angiography revealed extensive peripheral AVM in both lungs (Fig. 4D) and a probable arterioportal shunt involving the liver. Selective coil embolization of the AVM in the lung was performed twice, and the dyspnea was ameliorated.
###end p 19
###begin title 20
Mutation analysis
###end title 20
###begin p 21
###xml 25 28 25 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ENG</italic>
###xml 198 201 198 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ENG</italic>
###xml 285 287 285 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 387 390 387 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ENG</italic>
###xml 538 544 538 544 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACVRL1</italic>
###xml 743 749 743 749 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACVRL1</italic>
###xml 825 831 825 831 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Fig. 5</xref>
###xml 75 83 <span type="species:ncbi:9606">patients</span>
###xml 220 227 <span type="species:ncbi:9606">patient</span>
###xml 275 283 <span type="species:ncbi:9606">patients</span>
###xml 290 297 <span type="species:ncbi:9606">Patient</span>
###xml 570 578 <span type="species:ncbi:9606">patients</span>
###xml 593 600 <span type="species:ncbi:9606">patient</span>
###xml 616 623 <span type="species:ncbi:9606">patient</span>
###xml 909 917 <span type="species:ncbi:9606">patients</span>
Direct sequencing of the ENG gene was performed initially for all the five patients with HHT. A nonsense mutation producing a premature stop signal at codon 93 (c.277C>T; p.Arg93X) in exon 3 of the ENG gene was found in patient 1, which has previously been reported in HHT-1 patients (23). Patient 2 had a base substitution at a consensus splicing acceptor site of the 9th intron of the ENG gene (c.992-1G>C) predicting a splicing defect. This mutation has not been reported previously. We additionally performed direct sequencing of the ACVRL1 gene for three remaining patients and found one patient with mutation; patient 3 had a novel a frameshift mutation as a result of a duplication of one base pair in the coding region (exon 2) of the ACVRL1 gene producing a premature termination codon (c.81dupT; p.Arg28 SerfsX10) (Fig. 5). We could not perform further genetic analysis on the family members of the patients with mutation.
###end p 21
###begin p 22
###xml 57 60 57 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ENG</italic>
###xml 65 71 65 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACVRL1</italic>
###xml 117 122 117 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMAD4</italic>
###xml 218 221 218 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ENG</italic>
###xml 225 231 225 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACVRL1</italic>
###xml 328 333 328 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BMPR2</italic>
###xml 571 576 571 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BMPR2</italic>
###xml 6 14 <span type="species:ncbi:9606">patients</span>
###xml 251 259 <span type="species:ncbi:9606">patients</span>
###xml 530 538 <span type="species:ncbi:9606">patients</span>
Since patients 4 and 5 did not have any mutations in the ENG and ACVRL1 genes, we additionally screened them for the SMAD4 genes, but the results were negative. Subsequent MLPA analysis found no gross deletions in the ENG or ACVRL1 genes in these two patients. Because the P093 HHT/PPH1 MLPA kit also covers the 13 exons of the BMPR2 gene, the causative gene for primary pulmonary hypertension which sometimes shares identical pulmonary manifestations with HHT, we could get additional information on this gene. The remaining two patients showed negative results for the BMPR2 gene.
###end p 22
###begin title 23
DISCUSSION
###end title 23
###begin p 24
###xml 0 7 0 7 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 395 397 395 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 399 401 399 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 559 561 559 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 563 565 563 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 566 568 566 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 1031 1033 1031 1033 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 1391 1393 1391 1393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 1395 1397 1395 1397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 96 104 <span type="species:ncbi:9606">patients</span>
###xml 285 292 <span type="species:ncbi:9606">patient</span>
###xml 321 329 <span type="species:ncbi:9606">patients</span>
###xml 443 451 <span type="species:ncbi:9606">patients</span>
###xml 530 538 <span type="species:ncbi:9606">patients</span>
###xml 643 651 <span type="species:ncbi:9606">patients</span>
###xml 883 891 <span type="species:ncbi:9606">patients</span>
###xml 954 962 <span type="species:ncbi:9606">patients</span>
###xml 1003 1011 <span type="species:ncbi:9606">patients</span>
###xml 1070 1078 <span type="species:ncbi:9606">patients</span>
###xml 1191 1198 <span type="species:ncbi:9606">Patient</span>
###xml 1541 1548 <span type="species:ncbi:9606">patient</span>
Table 1 gives a summary of the clinical features and results of mutation analysis. All the five patients showed the typical manifestations of HHT with variable individual expression of the clinical features. The onset of epistaxis was rather late in these cases (with the exception of patient 5) compared with normal HHT patients, in whom most manifest recurrent epistaxis before the age of 20 (15, 24). Pulmonary AVM was observed in all five patients, which is believed to be somewhat unusual considering that only 15-30% of HHT patients have pulmonary AVM (15, 25-27). This might be due to the probable selection bias in this study in those patients with severe clinical manifestations such as pulmonary AVM are referred to our hospital for an evaluation of HHT. However, there remains a possibility that high prevalence of pulmonary AVM might be a unique characteristic in Korean patients with HHT; our review of all the literatures addressing Korean patients with HHT found that 13 out of 22 (-59%) patients had pulmonary AVM (28). Further studies on a large set of patients would be needed to clarify these issues, investigating genetic and environmental factors in Korean populations. Patient 5 had relatively severe clinical manifestations such as infantile cyanosis resulting from a congenital pulmonary AVM, which is quite unusual with very few cases (<30) being reported thus far (27, 29). This might be because most cases of congenital AVM are asymptomatic. This suggests that there might be a specific genetic background in this patient.
###end p 24
###begin p 25
###xml 26 29 26 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ENG</italic>
###xml 31 37 31 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACVRL1</italic>
###xml 43 48 43 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMAD4</italic>
###xml 148 151 148 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ENG</italic>
###xml 155 161 155 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACVRL1</italic>
###xml 521 523 515 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 525 527 519 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 575 578 569 572 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ENG</italic>
###xml 738 739 732 733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 1315 1318 1309 1312 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ENG</italic>
###xml 1374 1380 1368 1374 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACVRL1</italic>
###xml 1576 1578 1567 1569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 1580 1582 1571 1573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 1639 1645 1630 1636 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACVRL1</italic>
###xml 74 82 <span type="species:ncbi:9606">patients</span>
###xml 604 612 <span type="species:ncbi:9606">patients</span>
###xml 758 765 <span type="species:ncbi:9606">patient</span>
###xml 926 933 <span type="species:ncbi:9606">patient</span>
###xml 1585 1592 <span type="species:ncbi:9606">Patient</span>
###xml 1911 1918 <span type="species:ncbi:9606">patient</span>
Molecular analysis of the ENG, ACVRL1, and SMAD4 genes in the five Korean patients with HHT revealed three individuals with mutations in either the ENG or ACVRL1 genes. Endoglin is a membrane protein of the disulphide-linked homodimer that is expressed mainly in the endothelial cells of all vessels. This molecule binds the transforming growth factor-beta (TGF-beta), which is a powerful mediator of vascular remodeling induced by various stimuli such as vascular wall stress, and forms a signaling heteromeric complex (26, 30). The vast majority (-80%) of mutations of the ENG gene identified in HHT-1 patients are premature stop codons and truncated polypeptides, which appear to act as null alleles resulting in a haploinsufficiency (2). The mutation in patient 1 is a nonsense mutation located in the extracellular domain of the endoglin molecule predicting truncated protein with loss of the transmembrane domain, while patient 2 had a splice site mutation at the highly conserved sequence of the acceptor site of exon 7. Mutation analysis of the family members could not be carried out due to the unavailability of specimens. However, considering the obvious expectation of the abnormal mutant products, those family members with the typical features of HHT are believed to possess the same mutations on the ENG gene. The activin A receptor type II-like 1 encoded by ACVRL1 belongs to the TGF-beta superfamily receptor group, which signals through Smad1/5. Moreover, this molecule is expressed almost exclusively in endothelial cells, particularly during angiogenesis (31, 32). Patient 3 had a duplication mutation on exon 2 of the ACVRL1 gene, which is one of mutational hot spot and encodes part of the extracellular domain, predicting a frameshift and very short truncated protein removing the cystein rich (extracellular), transmembrane, kinase, and intracellular domain. The truncation mutations in patient 1 and 3 might fit into the haplo-insufficiency model rather than the dominant-negative model, because the mutant proteins lack the transmembrane domain and they would have less chance to form a heterodimer with normal protein.
###end p 25
###begin p 26
###xml 103 106 103 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ENG</italic>
###xml 111 117 111 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACVRL1</italic>
###xml 177 179 177 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 181 183 181 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 384 386 384 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 388 390 388 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35">35</xref>
###xml 427 430 427 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ENG</italic>
###xml 435 441 435 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACVRL1</italic>
###xml 750 752 750 752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 754 756 754 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 837 840 837 840 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ENG</italic>
###xml 845 851 845 851 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACVRL1</italic>
###xml 927 929 927 929 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 971 976 971 976 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMAD4</italic>
###xml 1077 1082 1077 1082 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMAD4</italic>
###xml 1157 1159 1157 1159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">36</xref>
###xml 1191 1196 1191 1196 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMAD4</italic>
###xml 494 502 <span type="species:ncbi:9606">patients</span>
###xml 779 787 <span type="species:ncbi:9606">patients</span>
###xml 1205 1213 <span type="species:ncbi:9606">patients</span>
There is significant phenotypic variability and genetic heterogeneity in HTT. Sequence analysis of the ENG and ACVRL1 genes reveals mutations in 60-80% of individuals with HHT (33, 34). Several techniques including quantitative PCR, MLPA and southern blot analysis can identify those deletions undetectable by sequence analysis, which can increase the detection rate by up to 10-20% (14, 35). However, mutation analysis of the ENG and ACVRL1 genes can fail to detect mutations in the remaining patients. This suggests the possibility of mutations in the non-coding regions of these genes or mutations in other genes. Recently, linkage analysis in two HHT families identified new HHT loci: HHT-3 in chromosome 5q31.3-32, and HHT-4 in chromosome 7p14 (19, 20). It is possible that patients 4 and 5, who tested negative to mutations in the ENG and ACVRL1 genes, might have mutations in another unidentified gene. Gallione et al. (21) recently reported that mutations in the SMAD4 tumor suppressor gene might be associated with a combined syndrome of JPHT. Because some cases with SMAD4 mutations show clinical manifestations of HHT without juvenile polyposis (36), we screened mutations in the SMAD4 gene in patients 4 and 5, and the results were negative.
###end p 26
###begin p 27
###xml 181 182 181 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 183 184 183 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 446 448 446 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 783 791 <span type="species:ncbi:9606">patients</span>
###xml 897 905 <span type="species:ncbi:9606">patients</span>
###xml 967 975 <span type="species:ncbi:9606">patients</span>
###xml 1067 1075 <span type="species:ncbi:9606">patients</span>
HHT occurs with a wide ethnic and geographic distribution. The prevalence of HHT has been reported to range from -1:1,300 to -1:40,000 depending on the geographic or ethnic region (2-9). Moreover, the type and frequency of specific mutations in different localities can vary widely with some regions having a specific founder mutation. For example, a study in France and northern Italy revealed higher frequency (-2.7 times) of HHT-2 than HHT-1 (15). The prevalence of HHT in the Korean population appears to be low with only occasional cases being reported thus far. However, the precise incidence, clinical characteristics, and genetic background of HHT in the Korean population are unknown because no epidemiological surveys have been carried out. Although only a small number of patients were investigated, this study indicates that there might be a specific clinical difference in Korean HHT patients. This highlights the need for more studies on a large set of patients in this regional population. Furthermore, more studies on the genetic background of Korean patients with HHT as well as the identification of another causative gene is needed. It is expected that such studies will help us better understand this serious but overlooked disorder and develop more appropriate therapeutic strategies.
###end p 27
###begin p 28
###xml 31 68 31 68 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Samsung Biomedical Research Institute</funding-source>
###xml 78 93 78 93 <award-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SBRI C-A6-403-2</award-id>
This work was supported by the Samsung Biomedical Research Institute grant, # SBRI C-A6-403-2.
###end p 28
###begin article-title 29
Clinical spectrum of hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease)
###end article-title 29
###begin article-title 30
Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease
###end article-title 30
###begin article-title 31
The prevalence and manifestations of hereditary hemorrhagic telangiectasia in the Afro-Caribbean population of the Netherlands Antilles: a family screening
###end article-title 31
###begin article-title 32
Hereditary haemorrhagic telangiectasia: a clinical analysis
###end article-title 32
###begin article-title 33
Hereditary hemorrhagic telangiectasia
###end article-title 33
###begin article-title 34
Genetic epidemiology of hereditary hemorrhagic telangiectasia in a local community in the northern part of Japan
###end article-title 34
###begin article-title 35
###xml 103 111 <span type="species:ncbi:9606">patients</span>
Hereditary haemorrhagic telangiectasia: a population-based study of prevalence and mortality in Danish patients
###end article-title 35
###begin article-title 36
Genetic aspects of Rendu-Osler disease in Haut-Jura: convergence of methodological approaches of historic demography and medical genetics
###end article-title 36
###begin article-title 37
Age-related clinical profile of hereditary hemorrhagic telangiectasia in an epidemiologically recruited population
###end article-title 37
###begin article-title 38
Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome)
###end article-title 38
###begin article-title 39
Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1
###end article-title 39
###begin article-title 40
A second locus for hereditary hemorrhagic telangiectasia maps to chromosome 12
###end article-title 40
###begin article-title 41
Genotype-phenotype correlation in hereditary hemorrhagic telangiectasia: mutations and manifestations
###end article-title 41
###begin article-title 42
Novel mutations in ENG and ACVRL1 identified in a series of 200 individuals undergoing clinical genetic testing for hereditary hemorrhagic telangiectasia (HHT): correlation of genotype with phenotype
###end article-title 42
###begin article-title 43
Genotype-phenotype correlations in hereditary hemorrhagic telangiectasia: data from the French-Italian HHT network
###end article-title 43
###begin article-title 44
Genotype-phenotype relationship in hereditary haemorrhagic telangiectasia
###end article-title 44
###begin article-title 45
Hereditary haemorrhagic telangiectasia: a questionnaire based study to delineate the different phenotypes caused by endoglin and ALK1 mutations
###end article-title 45
###begin article-title 46
Mutant endoglin in hereditary hemorrhagic telangiectasia type 1 is transiently expressed intracellularly and is not a dominant negative
###end article-title 46
###begin article-title 47
A new locus for hereditary haemorrhagic telangiectasia (HHT3) maps to chromosome 5
###end article-title 47
###begin article-title 48
A fourth locus for hereditary hemorrhagic telangiectasia maps to chromosome 7
###end article-title 48
###begin article-title 49
A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4)
###end article-title 49
###begin article-title 50
Topical estrogens combined with argon plasma coagulation in the management of epistaxis in hereditary hemorrhagic telangiectasia
###end article-title 50
###begin article-title 51
Identification of hereditary hemorrhagic telangiectasia type 1 in newborns by protein expression and mutation analysis of endoglin
###end article-title 51
###begin article-title 52
Epistaxis in hereditary haemorrhagic telangiectasia
###end article-title 52
###begin article-title 53
Hereditary hemorrhagic telangiectasia: an update on clinical manifestations and diagnostic measures
###end article-title 53
###begin article-title 54
A rare and misdiagnosed bleeding disorder: hereditary hemorrhagic telangiectasia
###end article-title 54
###begin article-title 55
###xml 96 104 <span type="species:ncbi:9606">patients</span>
Pulmonary arteriovenous malformations in hereditary hemorrhagic telangiectasia: a series of 126 patients
###end article-title 55
###begin article-title 56
KoreaMed
###end article-title 56
###begin article-title 57
Pulmonary arteriovenous malformation mimicking congenital cystic adenomatoid malformation in a newborn
###end article-title 57
###begin article-title 58
###xml 20 25 <span type="species:ncbi:9606">human</span>
Structural model of human endoglin, a transmembrane receptor responsible for hereditary hemorrhagic telangiectasia
###end article-title 58
###begin article-title 59
Activin receptor-like kinases: a novel subclass of cell-surface receptors with predicted serine/threonine kinase activity
###end article-title 59
###begin article-title 60
Arterial endothelium-specific activin receptor-like kinase 1 expression suggests its role in arterialization and vascular remodeling
###end article-title 60
###begin article-title 61
Molecular screening of ALK1/ACVRL1 and ENG genes in hereditary hemorrhagic telangiectasia in France
###end article-title 61
###begin article-title 62
###xml 62 70 <span type="species:ncbi:9606">patients</span>
High frequency of ENG and ALK1/ACVRL1 mutations in German HHT patients
###end article-title 62
###begin article-title 63
Characterization of 17 novel endoglin mutations associated with hereditary hemorrhagic telangiectasia
###end article-title 63
###begin article-title 64
###xml 40 48 <span type="species:ncbi:9606">patients</span>
SMAD4 mutations found in unselected HHT patients
###end article-title 64
###begin p 65
###xml 40 41 40 41 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 113 114 113 114 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 158 159 158 159 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 224 225 224 225 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 283 284 283 284 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 333 334 333 334 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
###xml 29 37 <span type="species:ncbi:9606">patients</span>
###xml 101 108 <span type="species:ncbi:9606">patient</span>
###xml 146 153 <span type="species:ncbi:9606">patient</span>
###xml 212 219 <span type="species:ncbi:9606">patient</span>
###xml 271 278 <span type="species:ncbi:9606">patient</span>
###xml 317 324 <span type="species:ncbi:9606">patient</span>
###xml 382 389 <span type="species:ncbi:9606">patient</span>
Clinical features of the HHT patients: (A) telangiectasia on the periungal regions of the fingers of patient 1, (B) telangiectasia on the lips of patient 1, (C) telangiectasia on the oral mucosa of the father of patient 2, (D) bleeding foci in the Kisselbach's plexus of patient 3; (E) microtelangia on the tongue of patient 5, and (F) clubbing fingers with one small hemangioma in patient 5.
###end p 65
###begin p 66
###xml 26 27 26 27 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 44 45 44 45 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 29 36 <span type="species:ncbi:9606">patient</span>
###xml 47 54 <span type="species:ncbi:9606">patient</span>
Pedigrees of families of (A) patient 1 and (B) patient 2.
###end p 66
###begin p 67
###xml 41 42 41 42 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 49 50 49 50 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 259 260 259 260 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 267 268 267 268 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 30 38 <span type="species:ncbi:9606">patients</span>
###xml 83 90 <span type="species:ncbi:9606">patient</span>
###xml 286 293 <span type="species:ncbi:9606">patient</span>
Radiology findings of the HHT patients. (A) and (B) CT angiography of the liver in patient 1 shows an enlarged celiac axis (arrow), a prominent hepatic artery (arrowhead) with multiple aberrant collateral vessels, and heterogeneous attenuation of the liver. (C) and (D) Abdominal CT of patient 3 shows severe tortuous dilatation of the hepatic artery (arrow) and its intrahepatic branches (arrowhead) with mottled hepatic enhancement.
###end p 67
###begin p 68
###xml 44 45 44 45 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 113 114 113 114 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 188 189 188 189 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 221 222 221 222 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 33 41 <span type="species:ncbi:9606">patients</span>
###xml 101 108 <span type="species:ncbi:9606">patient</span>
###xml 176 183 <span type="species:ncbi:9606">patient</span>
###xml 209 216 <span type="species:ncbi:9606">patient</span>
###xml 252 259 <span type="species:ncbi:9606">patient</span>
Pulmonary angiography of the HHT patients. (A) a large pulmonary arteriovenous malformation (AVM) in patient 2; (B) a new small-sized pulmonary AVM in the right middle lobe in patient 3; (C) multifocal AVM in patient 4; (D) extensive peripheral AVM in patient 5.
###end p 68
###begin p 69
###xml 66 67 66 67 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 108 109 108 109 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 159 160 159 160 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 46 54 <span type="species:ncbi:9606">patients</span>
###xml 96 103 <span type="species:ncbi:9606">patient</span>
###xml 147 154 <span type="species:ncbi:9606">patient</span>
###xml 201 208 <span type="species:ncbi:9606">patient</span>
Sequencing results of three mutation-positive patients with HHT. (A) ENG c.277C>T (p.Arg93X) in patient 1; (B) ENG c.992-1G>C (splicing defect) in patient 2; (C) ACVRL1 c.81dupT (p. Arg 28SerfsX10) in patient 3.
###end p 69
###begin p 70
###xml 58 66 <span type="species:ncbi:9606">patients</span>
Clinical features and mutations identified in five Korean patients with HHT
###end p 70
###begin p 71
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
*Novel mutations.
###end p 71
###begin p 72
HHT, hereditary hemorrhagic telangiectasia; AVM, arteriovenous malformation; CNS, central nervous system; GI, gastrointestinal; PFO, patent foramen ovale.
###end p 72

